NASDAQ
Comera Life Sciences Holdings, Inc. (CMRA) has a eps (diluted) of $-1.76 as of Saturday, December 31, 2022. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.